Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. Brain scans and imaging

Topic: Amyloid, tau and blood-test diagnosis

Alzheimer’s disease (AD) is a slow-growing neurological disorder that destroys human thought and consciousness. This disease directly affects the development of mental ability and neurocognitive function. The number of Alzheimer’s patients is increasing day by day, especially in the elderly over 60 years of age, and it gradually becomes a cause of their death. Machine learning (ML) and deep learning (DL) approaches have been developed in the literature to improve the diagnosis and classification of AD. Machine learning approaches have cumbersome feature selection. Deep learning has been used in recent research because it automatically selects features. This research aims to present a Swin Transformer wavelet for Alzheimer’s classification based on structural MRI images in two-class, three-class and four-class modes. The proposed approach uses wavelet fusion in the Swin Transformer network to extract features. The outputs of the modified capsule are fed into a wavelet as feature vectors. The wavelet is a relevant feature selector in the proposed model. The Gray Wolf Optimization (GWO) method was used to find the model’s hyperparameters. The proposed approach achieved an accuracy of 0.9812 in 4-class classification, 0.9980 in 3-class classification, and 1.0 in 2-class classification. In the studies conducted in this research, the Swin Transformer wavelet+GWO model is the heaviest model in terms of the evaluation criteria Parameters(10e6), GFlops, and Memory (GB). This is while the EfficientNet model is the lightest in these criteria. • A hybrid deep learning framework combining Swin Transformer, wavelet transform, and Gray Wolf Optimization is proposed for multi-class Alzheimers disease MRI classification. • Wavelet decomposition enhances multi-scale frequency feature extraction, improving discrimination between dementia stages compared with baseline CNN models. The proposed model achieves high performance across 2-class, 3-class, and 4-class Alzheimers classification tasks, reaching up to 0.98120.9875 accuracy in four-class experiments. • Gray Wolf Optimization effectively tunes model hyperparameters and contributes to consistent performance improvements over transfer-learning baselines. • Grad-CAM visualization is incorporated to enhance interpretability and provide clinically meaningful insight into model decision regions.

Key findings

Why it matters

This study used a deep learning method combining a Swin Transformer, wavelet transform and Gray Wolf Optimization to classify MRI scans into two, three or four Alzheimer's categories, reporting high accuracy. It is a diagnostic classification tool only and does not test any treatment, cure or prevention.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 2 of 5; Impact for its field and year 6 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 0 of 4; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 40 of 100.40 of 100 points earned60 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Intelligence-Based Medicine)
Journal's citation record 0 / 4 Intelligence-Based Medicine: journal h-index 31 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 11 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 5.5 citations a year over 2 year(s) since 2026
Impact for its field and year 6 / 6 Cited 52.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 11 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Saba Hesaraki: h-index 2 (OpenAlex, whole career)
Institution's track record 1 / 3 Tehran University of Medical Sciences: institution h-index 810 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 7 institution(s) in 2 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Nejad, A. R., Salimi, F. S. S., Hemmasian, M., Mirzaee, S., Abdiyeva, K., Mousa, R., et al. (2026). Multi-class Alzheimer’s disease (AD) classification using Swin Transformer wavelet and Gray Wolf Optimization (GWO). Intelligence-Based Medicine. https://doi.org/10.1016/j.ibmed.2026.100362

Vancouver

Nejad AR, Salimi FSS, Hemmasian M, Mirzaee S, Abdiyeva K, Mousa R, et al. Multi-class Alzheimer’s disease (AD) classification using Swin Transformer wavelet and Gray Wolf Optimization (GWO). Intelligence-Based Medicine. 2026. doi:10.1016/j.ibmed.2026.100362.

BibTeX

@article{nejad2026-32aff6e9,
  author  = {Nejad, Aida Rezaei and Salimi, Faeze Sadat Sadati and Hemmasian, Mahdi and Mirzaee, Saeed and Abdiyeva, Khabiba and Mousa, Ramin and Hesaraki, Saba},
  title   = {{Multi-class Alzheimer’s disease (AD) classification using Swin Transformer wavelet and Gray Wolf Optimization (GWO)}},
  journal = {Intelligence-Based Medicine},
  year    = {2026},
  doi     = {10.1016/j.ibmed.2026.100362},
  url     = {https://doi.org/10.1016/j.ibmed.2026.100362}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Brain scans and imaging

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →